Publications by authors named "Maria Filartiga"
Article Synopsis
- The study explored a new biological acellular vascular conduit (TRUE AVC™) for hemodialysis access, aimed at improving the limitations of traditional methods like early thrombosis and failed maturation.
- Five patients were involved in the clinical trial, receiving the conduit implanted in their upper arms; follow-up evaluations showed promising blood flow rates and no significant complications up to 26 weeks post-surgery.
- Results indicated an 80% primary assisted patency rate and 100% secondary patency over six months, suggesting that this novel conduit is a safe and viable option for dialysis access in individuals with end-stage kidney disease.
